Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Expanded flora test of topical octenidine and octenidine + prednicarbate formulations in healthy volunteers
2009-009948-23Phase 2Completed
- Sponsor
- Almirall
- Start
- Mar 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of octenidine and prednicarbate (4 arms), sponsored by Almirall. Primary endpoint: Colony forming unit counts for skin surface bacteria. Started Mar 2009; status: completed.
02
Drugs
octenidineprednicarbate
Beyond the preview
Go deeper on 2009-009948-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009948-23.